Share

Racing News

Frank Schleck appears before Luxembourg Anti-Doping Agency

Frank Schleck (RadioShack-Nissan-Trek) has appeared again before the Luxembourg Anti-Doping Agency (ALAD).

Frank Schleck denies knowingly taking the banned diuretic, Xipamide

Schleck, 32, tested positive for the diuretic, Xipamide, during the 2012 Tour de France, from which he voluntarily withdrew.

His B-sample was also returned positive, and he has not raced since.

Schleck denies taking the drug knowingly, claiming it was ingested accidentally or as the result of poisoning.

Schleck had a two-hour hearing last night in Luxembourg, after which he said he had maintained that he was not at fault.

“The investigation is continuing but it’s not over,” he added.

Schleck appeared before ALAD’s disciplinary committee on August 29.

He is a four-time champion of Luxembourg, and finished third in the 2011 Tour de France, behind his brother and teammate, Andy, and winner, Cadel Evans (BMC Racing).

Schleck endured a difficult 2012, whose highlight was second in the Tour de Suisse.

He briefly led RadioShack-Nissan-Trek at the Tour de France, but saw his chances of a high overall placing end with a crash on stage six that cost him more than two minutes and ended the hopes of a host of contenders.

Schleck has participated in RadioShack-Nissan-Trek’s pre-season training camp.

RadioShack-Nissan-Trek

Share

Newsletter Terms & Conditions

Please enter your email so we can keep you updated with news, features and the latest offers. If you are not interested you can unsubscribe at any time. We will never sell your data and you'll only get messages from us and our partners whose products and services we think you'll enjoy.

Read our full Privacy Policy as well as Terms & Conditions.

production